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Abstract
Genome-wide association studies (GWAS) have identified more than 2,000 trait-SNP associations, and the number continues
to increase. GWAS have focused on traits with potential consequences for human fitness, including many immunological,
metabolic, cardiovascular, and behavioral phenotypes. Given the polygenic nature of complex traits, selection may exert its
influence on them by altering allele frequencies at many associated loci, a possibility which has yet to be explored
empirically. Here we use 38 different measures of allele frequency variation and 8 iHS scores to characterize over 1,300
GWAS SNPs in 53 globally distributed human populations. We apply these same techniques to evaluate SNPs grouped by
trait association. We find that groups of SNPs associated with pigmentation, blood pressure, infectious disease, and
autoimmune disease traits exhibit unusual allele frequency patterns and elevated iHS scores in certain geographical
locations. We also find that GWAS SNPs have generally elevated scores for measures of allele frequency variation and for iHS
in Eurasia and East Asia. Overall, we believe that our results provide evidence for selection on several complex traits that has
caused changes in allele frequencies and/or elevated iHS scores at a number of associated loci. Since GWAS SNPs
collectively exhibit elevated allele frequency measures and iHS scores, selection on complex traits may be quite widespread.
Our findings are most consistent with this selection being either positive or negative, although the relative contributions of
the two are difficult to discern. Our results also suggest that trait-SNP associations identified in Eurasian samples may not be
present in Africa, Oceania, and the Americas, possibly due to differences in linkage disequilibrium patterns. This observation
suggests that non-Eurasian and non-East Asian sample populations should be included in future GWAS.
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Introduction
Genome-wide association studies (GWAS) have become a
popular method for identifying genomic loci that contribute to
complex traits [1]. In GWAS, large sample sets of individuals (now
on the order of several thousand), whose phenotype for some trait
has been assessed, are genotyped for common SNPs. Algorithms
are then used to identify SNPs that demonstrate allele frequency
differences between cases and controls or between persons
representing opposite ends of the phenotypic range (for continuous
traits such as height) [1]. It remains controversial how often the
alleles at these SNPs themselves have direct effects on the
phenotype under study; it is likely that in many cases these SNPs
instead act as markers linked to the causal genomic variants [2,3].
Nonetheless, numerous individual SNPs have significant trait
associations in more than one independent GWAS, confirming the
association between these SNPs and particular human phenotypes
[4,5]. As it is increasingly common for complex traits to have been
the focus of multiple independent GWAS, it is now possible to
discern which SNPs are most likely to have true trait associations
and which are likely false positives [5].
Most GWAS are conducted on subjects of European ancestry
[6]. As GWAS have reduced power to detect trait associations for
SNPs with low minor allele frequency (MAF), this means that most
‘‘GWAS SNPs’’ have a relatively high MAF in Europe [6].
Outside Europe, the allele frequencies of some GWAS SNPs vary
considerably. Perhaps the most cited examples of this are the SNPs
associated with pigmentation phenotypes, many of which exhibit
extreme allele frequency differences between continental groups
[7]. Other examples of individual GWAS SNPs with large allele
frequency differences between particular pairs of continents have
been found, including variants associated with Type 2 Diabetes
and Crohn’s disease [7,8]. However, most individual GWAS SNPs
have allele frequency patterns that are indistinguishable from those
of random SNPs with no known trait associations [8,9].
An understanding of the global allele frequency distributions of
GWAS SNPs is important for two reasons. First, the frequency of a
trait-associated allele determines to what degree it can contribute
to variability in its phenotype in a given population. This is
particularly true for SNPs that contribute directly to phenotypic
variation rather than tagging causative variants [10]. Second, large
allele frequency differences between populations for trait-associat-
ed SNPs may indicate that selection has acted upon the trait [8].
Past studies of the allele frequency patterns of GWAS SNPs have
tended to be limited to particular human populations or pairs of
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associated with phenotypes thought to be likely targets of selection
(e.g. metabolic diseases like Type 2 Diabetes and resistance to
infectious pathogens) [7,8]. Additionally, these studies have
examined the allele frequency patterns of individual GWAS SNPs
rather than looking for commonalities in the behavior of groups of
SNPs associated with a particular trait or identified in a single
study [7,9,11]. Here we examine approximately 1,300 GWAS
SNPs associated with a wide variety of phenotypes. We explore the
allele frequency patterns of these SNPs in 53 globally distributed
populations using 4 different statistics. These statistics are
calculated for different population groupings in order to detect
individual GWAS SNPs and groups of SNPs that exhibit unusual
allele frequency patterns on a local and/or global level. While
pigmentation SNPs do seem to exhibit the most extreme variations
in allele frequency, we found that groups of SNPs associated with
blood pressure, infectious disease, and autoimmune disease also
differ from random groups of SNPs in their allele frequency
distributions.
Results
Dataset
We analyzed trait-associated SNPs reported by published
genome-wide association studies (GWAS) and cataloged online
by the National Human Genome Research Institute (NHGRI) [5].
As of April 1, 2010, this database contained 2,284 SNPs (both
autosomal and X-linked) that had reached genome-wide signifi-
cance in at least one GWAS. These SNPs were associated with a
total of 330 traits in 477 different studies (some SNPs have been
identified in multiple studies and some have been associated with
multiple traits). We investigated these SNPs in the dataset reported
by Li et al. [12], which contains information on 640,698
autosomal SNPs genotyped in 938 individuals of the Centre
D’Etude du Polymorphism Humaine-Human Genome Diversity
Project (CEPH-HGDP) collection. These individuals are members
of 53 globally distributed populations which can be divided into 8
continental groups [13,14]. Of the 2,259 autosomal SNPs that we
compiled from the NHGRI website, 1,336 are found in this
dataset. The remainder of this paper will focus mainly on these
1,336 SNPs, 592 of which were identified in more than one
GWAS (see Methods). The full set of 1,336 GWAS SNPs and this
subset of 592 (which we will refer to as ‘‘independently identified
SNPs’’) are handled separately in the analyses below.
GWAS Traits with Unusual Allele Frequency Distributions
and/or Elevated iHS Scores
Before beginning our primary analyses, we calculated the minor
allele frequencies (MAFs) in Europe of all autosomal SNPs from
the Li et al. [12] dataset (see Methods). GWAS studies have more
power to detect trait-SNP associations for SNPs with high MAF
[1], so GWAS SNPs are expected to have a higher average MAF
in Europe than the remaining SNPs in our dataset (see Text S1,
Figure S8, and Figure S9). This is indeed the case; we found that
there were proportionally more GWAS SNPs in all high MAF bins
(Figure 1A). GWAS SNPs are also expected to differ from the
other SNPs in our dataset in terms of their linkage disequilibrium
(LD) relationships with neighboring SNPs (see Text S1, Figure S8,
and Figure S9). SNPs that are in high LD with their neighbors
‘‘tag’’ larger regions of the genome than do SNPs that are not in
LD with surrounding variants. Because of this, the former are
more likely to tag a region of the genome containing a causative
variant for a particular GWAS trait. To quantify LD in our
dataset, we calculated an ‘‘LD score’’ (see Methods) for all 640,698
autosomal SNPs. Again we found that GWAS SNPs differ from
the remaining SNPs in the dataset in that proportionally more
GWAS SNPs were found to be in high LD with neighboring SNPs
(Figure 1B).
We used 3 statistics to characterize SNP allele frequency
distributions across the 53 CEPH-HGDP populations: (i) delta
values, which represent the difference in allele frequency between
two continental groups or populations, (ii) group Fst values, which
reflect the variation in allele frequency among populations in a
group of populations, and (iii) correlations with longitude and
latitude (we will refer to these as latitude/longitude correlation or
‘‘LLC’’ scores), which assess how closely changes in the allele
frequency of a SNP follow geographical coordinates. We also used
a fourth statistic, iHS [15] to characterize the lengths of the
haplotypes surrounding each allele of a SNP. We chose to use iHS
rather than other statistics that indicate genomic regions which
may have been subject to past selection, because previous studies
[8,9] have found few GWAS SNPs with large allele frequency
differences between populations (with the notable exception of
pigmentation SNPs). This suggests that the selective sweeps
affecting GWAS SNPs are likely to have been weak or incomplete
(see Text S2). Such sweeps are more effectively detected by iHS
than by other selection statistics [15]. We calculated each of these
four statistics for the pairs and groups of populations listed in
Table 1. For clarity, we will refer to a delta, Fst, LLC, or iHS value
calculated for a particular population or populations as a
‘‘measure’’ or ‘‘score’’.
We used these measures of allele frequency and haplotype
length to compare GWAS SNPs to SNPs from the CEPH-HGDP
dataset in three different ways. First, we assigned a p-value to each
individual GWAS SNP by comparing its value for a particular
allele frequency measure or iHS score to the values of other SNPs
from our full set of 640,698 autosomal SNPs. These ‘‘other SNPs’’
were similar to each GWAS SNP in terms of MAF and LD score
(see Methods for full details). For each delta, Fst, LLC, and iHS
measurement, SNPs with sufficiently extreme p-values were
Author Summary
Natural selection exerts its influence by changing allele
frequencies at genomic polymorphisms. Alleles associated
with harmful traits decrease in frequency while those
associated with beneficial traits become more common. In
a simple case, selection acts on a trait controlled by a
single polymorphism; a large change in allele frequency at
this polymorphism can eliminate a deleterious phenotype
from a population or fix a beneficial one. However, many
phenotypes, including diseases like Type 2 Diabetes,
Crohn’s disease, and prostate cancer, and physiological
traits like height, weight, and hair color, are controlled by
multiple genomic loci. Selection may act on such traits by
influencing allele frequencies at a single associated
polymorphism or by altering allele frequencies at many
associated polymorphisms. To search for cases of the
latter, we assembled groups of genomic polymorphisms
sharing a common trait association and examined their
allele frequencies across 53 globally distributed popula-
tions looking for commonalities in allelic behavior across
geographical space. We find that variants associated with
blood pressure tend to correlate with latitude, while those
associated with HIV/AIDS progression correlate well with
longitude. We also find evidence that selection may be
acting worldwide to increase the frequencies of alleles that
elevate autoimmune disease risk.
GWAS SNPs in the HGDP Populations
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and Table 4 for SNPs with significant p-values). We will refer to
this first phase of the analysis as the ‘‘individual SNP analysis’’.
Next, we divided our 1,336 GWAS SNPs into groups based on the
GWAS study that reported their trait association (some SNPs were
in multiple groups if they were identified in more than one study).
These ‘‘study groups’’ were then ‘‘pruned’’ by removing one SNP
of any pair that were less than 1MB apart; the remaining SNP was
the one with the smaller association p-value in the relevant
GWAS. Our objective in carrying out this pruning process was to
have in each study group one SNP (the one with the most
significant trait association) representing each trait-associated
genomic region. Groups with only one SNP remaining after this
process were removed from consideration in the following analysis.
For each delta, Fst, LLC, and iHS measure, each group was
assigned a score based on the measure values of all SNPs in the
group. As our group size ranged from n=2 to n=51 SNPs, we
created an empirical distribution for each measure and each group
size n (see Methods). We used these empirical distributions to
assign to each group a p-value for each measure. Finally, we used
the NHGRI website [5] to determine which allele was the risk
allele for 1,041 of our GWAS SNPs (the risk allele for GWAS
SNPs is not always identified). We were then able to assign a
signed value for all of our delta, LLC, and iHS measures to these
1,041 SNPs (see Methods). SNPs were again grouped according to
the study that identified them and we again created empirical
distributions for each measure and each group size (see Methods).
To distinguish between the two types of group analyses, we will
refer to the first as the ‘‘unsigned group analysis’’ and to the latter
as the ‘‘signed group analysis’’.
In the individual SNP analysis, three SNPs were significant for
one or more delta, Fst, LLC, or iHS measure. These three -
rs28777, rs1834640, and rs12913832 – were all associated with
pigmentation traits in GWAS (see Table 3 for a complete list of
SNPs with significant p-values). A total of 8 groups reached
significance for at least one measure in the unsigned group analysis
while 10 reached significance in the signed group analysis.
Included among these 10 were 3 pigmentation study groups that
were significant in both analyses. We observed three other study
groups that were significant in both analyses: an obesity study
group [16] containing SNPs whose allele frequencies were
significantly correlated with latitude in Eurasia, a hypertension
study group [17] whose SNPs were associated with latitude in
Africa, and a study group containing SNPs that are associated with
the rate of AIDS progression [18] that produced high iHS scores
in Europe. Other study groups were significant only in the
unsigned or signed group analysis. SNPs in a psoriasis study group
[19] produced high Fst scores in the African Agriculturists in the
unsigned analysis, while a study group of SNPs associated with
lung adenocarcinoma [20] and another containing SNPs associ-
ated with response to treatment for acute lymphoblastic leukemia
(ALL) [21] were significant only in the signed analysis.
SNPs and study groups associated with pigmentation and
immunological traits made up a majority of those that reached
significance in our analysis. To test whether any of these general
trait categories were enriched for SNPs producing large delta, Fst,
LLC, or iHS scores, we divided the GWAS SNPs into 18 groups
based on the trait with which they were associated. These 18
groups, which we will call ‘‘trait classes’’, are listed in Table S1.
For each of the 128 lists of p-values (there are a total of 45 delta,
Fst, LLC, and iHS measures each in the individual SNP and
unsigned group analyses and 38 total measures in the signed group
analysis), we identified trait classes with a large number of SNPs or
study groups with p-values less than or equal to 0.05 (see Methods
for details and Figure S1 for full results). For the individual SNP
analysis, there were a large number of delta, Fst, LLC, and iHS
measures (12 and 9, respectively) for which pigmentation and
autoimmune disease SNPs were over-represented in the top 5% of
the empirical distribution. Pigmentation SNPs tended to produce
low p-values for delta, Fst, and LLC measurements involving
Eurasian and East Asian populations while autoimmune disease
SNPs produced high iHS scores and correlated well with latitude
on several continents. Pigmentation study groups had low p-values
for many of the same delta, Fst, LLC, and iHS measures in the
unsigned and signed group analyses. The measures for which
autoimmune disease SNPs/study groups had low p-values varied
somewhat across the phases of analysis, but in all phases they
tended to produce high iHS scores.
Blood pressure SNPs and study groups were also over-
represented in the top 5% of the empirical distribution for 10
Figure 1. Histograms of SNP MAF and LD score in Europe. A) The blue bars represent the proportion of the 640,698 autosomal SNPs in the Li
et al. [12] dataset that have a European MAF in each MAF bin (see Methods). The red bars represent the proportion of the 1,336 GWAS SNPs that have
a European MAF in each MAF bin. B) The blue bars represent the proportion of the 640,698 autosomal SNPs that have an LD score in each LD score
bin (see Methods). The red bars represent the proportion of the 1,336 GWAS SNPs that have an LD score in each LD score bin. The bin referred to as
‘‘NA’’ contains all SNPs that are fixed in Europe.
doi:10.1371/journal.pgen.1001266.g001
GWAS SNPs in the HGDP Populations
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unsigned group analysis. These measures included several
Eurasian and East Asian delta, Fst, and iHS measures, but blood
pressure SNPs also had high scores for measures assessing allele
frequency correlation with latitude in Africa. Blood pressure study
groups did not have particularly low p-values for any measures in
the signed group analysis; this may have been due to the small
number of blood pressure study groups considered in this
particular phase of the analysis. Several other trait classes were
notable in two of the three phases of analysis. In the individual
analysis and the signed group analysis, the SNPs/study groups of
the infectious diseases trait class had low p-values for iHS scores in
the Middle East (iME), East Asia (iEA), and Oceania (iOceania)
and for measures of allele frequency correlation with latitude in
East Asia (LEALat and LEurasiaEALat). Additionally, the
metabolic trait class (which includes weight and Type 2 Diabetes
study groups) produced low p-values for a number of measures in
both the unsigned and signed group analysis, although the
measures varied between analyses.
We repeated all our above analyses focusing only on the 592
GWAS SNPs that were reported in more than one study (see
Methods for details). We will call these 592 SNPs ‘‘independently
identified’’ or II SNPs. The results were quite similar to those for
the full set of 1,336 GWAS SNPs with a few exceptions (Table 4).
A number of study groups included in our initial analysis were not
considered here because they contained fewer than two II SNPs.
Included among these was the hypertension study group [17]
whose SNPs significantly correlated with latitude in Africa
(LAfricaLatDE). However, we found that two other blood pressure
study groups containing SNPs associated with diastolic blood
pressure (DBP) [17,22] were significant for at least one measure in
our II unsigned group analysis. Both of these DBP study groups
were significant for allele frequency difference between Europe
and Central Asia (DEuropeCA) and one was significant for allele
frequency correlation with latitude in Eurasia (LEurasiaLat).
Again for each delta, Fst, LLC, and iHS measure, we looked for
trait classes containing a large number of SNPs or study groups
with p-values #0.05. Although the number of study groups in
some trait classes was quite small for the II analyses, the results
were still similar to those from our analysis of all GWAS SNPs.
The pigmentation and blood pressure trait classes again produced
Table 1. List of all 45 Delta, Fst, LLC, and iHS scores calculated
for the CEPH-HGDP populations.
Delta
Abbreviation Allele Frequency Difference Between:
DPymgy Biaka Pygmy Mbuti Pygmy
DHGAA African Hunter-Gatherers African Agriculturists
DAAME African Agriculturists
Agriculturists
Middle East
DAAEurope African Agriculturists
African
Agriculturists
Europe
DAACA African Agriculturists
African
Agriculturists
Central Asia
DAAEA African Agriculturists
African
Agriculturists
East Asia
DEuropeME Europe Middle East
DEuropeCA Europe Central Asia
DEuropeEA Europe East Asia
DMECA Middle East Central Asia
DMEEA Middle East East Asia
DCAEA Central Asia East Asia
DEAOceania East Asia Oceania
DEAAmerica East Asia America
Fst
Abbreviation Continent # of Populations
FHG African Hunter-Gatherers 3
FAA African Agriculturists
Agriculturists
4
FEurope Europe 8
FEurasia Eurasia 21
FEA East Asia 18
FAmerica America 5
FWorld World 53
Latitude/Longitude Correlation
Abbreviation Correlation with: Continent
LAfricaLat Latitude Africa
LAfricaLatDE Degrees from Equator* Africa
LAfricaLong Longitude Africa
LEuropeLat Latitude Europe
LEuropeLong Longitude Europe
LEurasiaLat Latitude Eurasia
LEurasiaLong Longitude Eurasia
LEALat Latitude East Asia
LEALong Longitude East Asia
LEurasiaEALat Latitude Eurasia and East Asia
LEurasiaEALong Longitude Eurasia and East Asia
LAmericaLat Latitude America
LAmericaLatDE Degrees from Equator* America
LAmericaLong Longitude America
LWorldLat Latitude World
LWorldLatDE Degrees from Equator* World
Latitude/Longitude Correlation
Abbreviation Correlation with: Continent
LWorldLong Longitude World
iHS
Abbreviation Continent/Population # of Populations
iBantu Bantu 2
iME Middle East 4
iEurope Europe 8
iCA Central Asia 9
iEA East Asia 18
iOceania Oceania 2
iAmerica America 5
*Correlation was calculated between allele frequency and the absolute value of
the latitude.
doi:10.1371/journal.pgen.1001266.t001
Table 1. Cont.
GWAS SNPs in the HGDP Populations
PLoS Genetics | www.plosgenetics.org 4 January 2011 | Volume 7 | Issue 1 | e1001266low p-values for more delta, Fst, LLC, and iHS measures than did
the other trait classes in the individual SNP and unsigned group
analyses. In one departure from previous observations, blood
pressure study groups also produced low p-values for a number of
measures in the signed group analysis. Additionally, we noted that
in the II unsigned group analysis, study groups of the
Table 2. Number of SNPs/study groups tested in each analysis.
Full Set of 1,336 CEPH-HGDP GWAS SNPs Subset of 592 Independently Identified (II) GWAS SNPs
Name
# of SNPs/Study
Groups
P-Value Cutoff for Signifi-
cance at 0.05 Level*
# of SNPs/Study
Groups
P-Value Cutoff for Signifi-
cance at 0.05 Level*
Individual SNP 1336 3.75610
25 592 8.45610
25
Unsigned Group 270 1.85610
24 152 3.29610
24
Signed Group 175 2.86610
24 121 4.13610
24
*The p-value cut-off was determined using the Bonferroni method to correct for the fact that we were testing multiple hypotheses (SNPs or study groups). The number
of tests in each analysis is the number of SNPs or study groups included in that analysis.
doi:10.1371/journal.pgen.1001266.t002
Table 3. Individual SNPs and study groups that were
significant for at least one Delta, Fst, LLC, or iHS measure in
the individual SNP, group unsigned, or group signed analysis
of all 1,336 GWAS SNPs.
Full Set of 1,336 GWAS SNPs
Individual SNPs
SNP Trait(s) Measure(s)
rs28777 Black vs. Blond Hair;
Black vs. Red Hair
DEuropeCA; FEurasia
rs1834640 Skin Pigmentation iME
rs12913832 Black vs. Blond Hair;
Black vs. Red Hair
FEurasia
Unsigned Study Group
Study* Trait(s) Measure(s)
Han Black vs. Blond Hair DEuropeME; DEuropeCA;
FEurope; FEurasia; LEurasiaLat
Han Black vs. Red Hair DEuropeME; DEuropeCA;
DEuropeEA; FEurope;
FEurasia; FWorld
Stokowski Skin Pigmentation DEuropeEA; DMEEA; DCAEA;
FEurasia; FWorld; iME
Liu Psoriasis FAA
Levy Hypertension LAfricaLatDE
Sulem(2) Blond vs. Brown Hair LEurasiaLat
Meyre Obesity LEurasiaLat
Limou HIV/AIDS Progression iEurope
Signed Study Group
Sulem(2) Blue vs. Green Eyes LEurasiaLat
Sulem(2) Blond vs. Brown Hair LEurasiaLat
Han Black vs. Red Hair DEuropeME
Stokowski Skin Pigmentation DEuropeEA; DMEEA;
DCAEA; iME; iCA
Levy Hypertension LAfricaLatDE
Nan Tanning LEurasiaLat
Meyre Obesity LEurasiaLat
Limou HIV/AIDS Progression iEurope
Landi Lung Adenocarcinoma iEurope
Yang Response to ALL Treatment DEAAmerica
*First author of GWAS study identifying SNPs included in the study group.
doi:10.1371/journal.pgen.1001266.t003
Table 4. Individual SNPs and study groups that were
significant for at least one Delta, Fst, LLC, or iHS measure in
the II individual SNP, group unsigned, or group signed
analysis.
Subset of 592 Independently Identified (II) GWAS SNPs
Individual SNPs
SNP Trait(s) Measure(s)
rs28777 Black vs. Blond Hair;
Black vs. Red Hair
DEuropeME; DEuropeCA;
FEurasia
rs12913832 Black vs. Blond Hair;
Black vs. Red Hair
FEurasia; LEurasiaLat
rs10484554 AIDS Progression; Psoriasis FAA
Unsigned Study Group
Study* Trait(s) Measure(s)
Han Black vs. Blond Hair DEuropeME; DEuropeCA;
FEurope; FEurasia; LEurasiaLat
Han Black vs. Red Hair DEuropeME; DEuropeCA;
DEuropeEA; FEurope; FEurasia;
FWorld
Sulem(2) Blue vs. Green Eyes LEurasiaLat
Sulem(2) Blond vs. Brown Hair LEurasiaLat
Newton-Cheh Diastolic Blood Pressure DEuropeCA
Levy Diastolic Blood Pressure DEuropeCA; LEurasiaLat
Liu Psoriasis FAA
Limou HIV/AIDS Progression iEurope
Signed Study Group
Sulem(2) Blue vs. Green Eyes LEurasiaLat
Sulem(2) Blond vs. Brown Hair LEurasiaLat
Han Black vs. Red Hair DEuropeME
Nan Tanning LEurasiaLat
Landi Lung Adenocarcinoma iEurope
Limou HIV/AIDS Progression iEurope
*First author of GWAS study identifying SNPs included in the study group.
doi:10.1371/journal.pgen.1001266.t004
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iHS and LLC measures in Eurasia and East Asia. Overall, our
analyses indicate that SNPs associated with pigmentation, blood
pressure, and autoimmune disease have unusual allele frequency
distributions (or elevated iHS scores) relative to random SNPs; to a
lesser degree, this is also true for SNPs associated with infectious
disease, metabolic, and hematological traits.
Comparing across Delta, Fst, LLC, and iHS Measures
There was considerable variability across p-value distributions
for different delta, Fst, LLC, and iHS measures. In particular,
GWAS SNPs generally seem to produce smaller p-values for
measures involving Eurasian and East Asian populations (Figure 2,
Figure S2, and Figure S3). This holds across all 6 p-value sets (one
set for the individual SNP, unsigned group, and signed group
analyses for both the full set of 1,336 GWAS SNPs and the subset
of 592 II GWAS SNPs) although there are some exceptions. Most
notably, the proportion of GWAS SNPs/study groups with p-
values #0.05 for Fst among American populations (FAmerica) and
for the correlation of allele frequencies with latitude (LAmerica-
Lat), distance from the equator (LAmericaLatDE), and longitude
(LAmericaLong) in America is quite high for some sets of p-values.
As pigmentation SNPs often have low p-values for Eurasian and
East Asian delta, Fst, LLC, and iHS measures, we re-evaluated all
p-value sets after removing pigmentation SNPs and study groups
from consideration. The proportion of SNPs/study groups with p-
values #0.05 was somewhat diminished for certain Eurasian
measures, especially delta values comparing Eurasian and East
Asian populations. However, non-pigmentation SNPs and study
groups still tended to produce smaller p-values for Eurasian and
East Asian delta, Fst, LLC, and iHS measures relative to other
measures.
Sample Ethnicity
Although GWAS once focused almost exclusively on individuals
of European ancestry, studies are now being conducted on cases
and controls from other human populations. We reviewed all 477
GWAS studies and found that 375 used only European subjects
(see Methods), 24 used only East Asian subjects, 2 used only
Oceanic subjects, one used only African subjects, and one used
only Native American subjects. The remaining studies used either
subjects from multiple continents or used human populations that
were the product of recent admixture (for example, Hispanic-
American individuals). We compiled a list of all GWAS SNPs and
study groups from studies using only European subjects (we will
call these ‘‘European GWAS SNPs/study groups’’) and a list of all
GWAS SNPs and study groups from studies using only East Asian
subjects (we will call these ‘‘East Asian GWAS SNPs/study
groups’’). We used these to determine whether there were any
measures with a large number of East Asian GWAS SNPs/study
groups with p-values in the top 5% of the empirical distribution
(see Methods and Figure S4 for complete results). We found that
this was true for East Asian GWAS study groups for American
LLC measures in the group analyses. We also compared the p-
values of European and East Asian GWAS SNPs/study groups for
each for delta, Fst, LLC, and iHS measure using an unpaired
Wilcoxon test (see Methods and Figure S5). East Asian GWAS
SNPs/study groups produced lower p-values (significant at the
0.05 level) for all three American LLC measures. East Asian
GWAS SNPs and study groups also tended to produce lower p-
values than European GWAS SNPs/study groups for FAmerica as
well as for the delta measure comparing allele frequencies between
the Biaka and Mbuti Pygmies (DPygmy). European GWAS SNPs
and study groups produced lower p-values than East Asian GWAS
SNPs/study groups for the two measures of allele frequency
correlation with latitude across all 53 CEPH-HGDP populations
(LWorldLat and LWorldLatDE).
Finally, we examined individual studies that used European and
East Asian samples to determine the relationship between the
SNPs associated with a particular trait in studies using individuals
from different continents. Are the SNPs associated with Trait X in
a European study the same as those identified in an East Asian
study? Among the GWAS that used East Asian subjects, we
identified four that focused on height [23–26], four that focused on
Type 2 Diabetes (T2D) [27–30], and two that focused on Systemic
Lupus Erythematosus (SLE), commonly called Lupus [31,32]. We
listed all SNPs associated with height in any study on the NHGRI
website [5] (regardless of the ethnicity of the study subjects). We
then identified genomic regions containing a ‘‘hit’’ in more than
one GWAS (see Methods). There were 26 such regions, two of
which were associated with height only in GWAS that used
exclusively East Asian samples. We then calculated minor allele
Figure 2. Proportion of SNPs and study groups with P-values #0.05 for iHS scores. A) The blue bars represent the proportion of individual
GWAS SNPs in the analysis of all 1,336 GWAS SNPs that had a p-value of 0.05 or less for each iHS score. The red bars represent the proportion of study
groups in the unsigned group analysis with a p-value of 0.05 or less for each iHS score. The green bars represent the proportion of study groups in
the signed group analysis with a p-value of 0.05 or less for each iHS score. B) The same as in A) except that the blue, red, and green bars represent the
II individual SNP, group unsigned, and group signed analyses, respectively.
doi:10.1371/journal.pgen.1001266.g002
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that although the MAFs of these SNPs were fairly high in East Asia
(16%–27%), they all fell to less than 5% in Europe, except in one
case. We made a similar observation for T2D and SLE. In both of
these cases, we found only one region that was associated with
T2D and SLE, respectively, in GWAS using only East Asian
samples. For T2D, this region, on the short arm of chromosome
11, contained SNPs with a MAF range of 3.8% to 5.1% in Europe.
The SLE region, on the long arm of chromosome 11, also
contained SNPs whose MAFs were smaller in Europe than in East
Asia, although in this case the European MAFs were all about
11%. Conversely, we find that genomic regions associated with
height, T2D, and SLE by GWAS using only European subjects
often contain SNPs with relatively high MAFs in East Asia (see
Figure S6).
Chromosome X
Of the 2,284 SNPs reported by the NHGRI website to be trait
associated, 26 were located on the X chromosome. 21 of these,
associated with traits like height, prostate cancer, LDL cholesterol,
and Type 1 Diabetes (T1D), were also found in the CEPH-HGDP
dataset. We calculated our delta, Fst, LLC, and iHS measures for
these SNPs and used the 16,297 X-linked SNPs from Li et al. [12]
to construct an empirical distribution for each measure (see
Methods and Figure S7 for details pertaining to MAFs and LD
scores for X-linked SNPs). The Bonferroni-corrected p-value cut-
off for significance at the 0.05 level was 2.38610
23 (since there
were 21 X-linked SNPs). Table 5 lists all X-linked SNPs that were
significant for at least one of our measures. Two out of the 21 X-
linked GWAS SNPs were associated with HIV/AIDS Progression
by Fellay et al. [33]. As these two SNPs are separated by 45MB on
the long arm of the X chromosome they are unlikely to be in
linkage disequilibrium with one another. However, both SNPs,
rs17324272 and rs12012519, were significant for the measure
assessing allele frequency correlation with longitude in Eurasia and
East Asia (LEurasiaEALong). rs17324272 was also significant for
LEALong and for iHS in East Asia (iEA). Overall, these two SNPs
have p-values less than 0.05 for many delta measures comparing
allele frequencies between the continents of Eurasia and East Asia
as well as many measures of allele frequency correlation with
longitude in Eurasia and East Asia. An X-linked height SNP,
rs1474563 [34], was also significantly correlated with latitude in
Europe (LEuropeLat). Paralleling our autosomal results, this SNP
was also the X-linked GWAS SNP with the largest allele frequency
difference between the two Pygmy groups; previously, we noted
that a height SNP produced the largest value for DPygmy out of
all 1,336 autosomal GWAS SNPs in the CEPH-HGDP dataset.
Of all the trait-associated X-linked SNPs, rs1474563 also had
the largest allele frequency difference between the Eurasian
continents and East Asia and the highest Fst scores among the
African Hunter-Gatherers, African Agriculturists, Europeans, and
Eurasians.
Discussion
The possible import of polygenic adaptation in humans, where
selection acts on a trait by affecting allele frequencies at many
associated polymorphisms, has been widely touted in recent
literature [35,36]. Empirical studies have found only a few
examples of variants that have undergone ‘‘hard sweeps’’, where
a favored allele arises by mutation and increases to high frequency
in a population [35,36]. Instead, it is now thought that adaptation
to new phenotypic optima may proceed through small allele
frequency changes at many polymorphic loci [35–37]. It is
important to note, however, that selection on traits need not be
limited to positive selection. Selection acts on traits not only to
achieve new phenotypic optima, but also to maintain those optima
once they have been reached, perhaps through balancing or
negative selection [38,39]. Here we used 45 different measures of
allele frequency variation and haplotype length to scan for
selection on traits examined by GWAS. We identified a total of
13 study groups that were significant for at least one measure in at
least one phase of the analysis. Although other explanations are
certainly possible (see Text S3), we believe that there is solid
evidence that these study groups represent instances of a polygenic
response to selective pressure on an associated trait. We give an
overview of the traits we found to be particularly notable below.
Pigmentation
The NHGRI Catalog [5] includes studies on a total of 14
pigmentation traits; we identified 6 of these as having associated
SNPs or study groups that were significant for at least one delta,
Fst, LLC, or iHS measure. We listed all SNPs identified as being
associated with at least one of the 14 pigmentation phenotypes and
found that the majority of these SNPs fell into one of 7 genomic
clusters, each of which is associated with a known pigmentation
gene – SLC45A2, IRF4, TYR, SLC24A4, HERC2, MC1R, and ASIP.
(As the focus of our work is specifically on GWAS and the SNPs
they have identified, only pigmentation genes associated with
GWAS hits are included in our discussion here.) Numerous
previous studies have found evidence for selection at loci
associated with pigmentation [15,40–50]. The majority of this
evidence has been found in European populations, but there have
also been reports of selection at pigmentation loci in East Asian
and African populations [41,45,47–50]. In our work, we noted
that pigmentation SNPs and study groups produced low p-values
(p-values #0.05) for three types of measures: delta values
comparing different Eurasian populations, Eurasian Fst measures
(FEurope and FEurasia), and LLC measures assessing allele
frequency correlation with latitude in Eurasia. There were almost
no cases where a pigmentation SNP or study group had a p-value
less than or equal to 0.05 for a measure not involving Eurasians.
Variation in pigmentation phenotypes is certainly not limited to
Eurasians nor is there any reason to believe that selection on loci
associated with pigmentation would be limited to Eurasia.
However, our results indicate that SNPs associated with
pigmentation in GWAS display unusual allele frequency patterns
almost exclusively in Europe, the Middle East, and Central Asia.
This suggests to us that there may be SNPs, perhaps in or near
genes other than SLC45A2, IRF4, TYR, SLC24A4, HERC2, MC1R,
and ASIP, which are associated with pigmentation in non-Eurasian
populations, but which have yet to be identified by GWAS.
Table 5. Individual SNPs that were significant for at least one
delta, Fst, LLC, or iHS measure in the X chromosome analysis.
21 X-Linked GWAS SNPs
Individual SNPs
SNPs Trait(s) Measure(s)
rs1474563 Height LEuropeLat
rs17324272 HIV/AIDS Progression LEALong; LEurasiaEALong;
iEA
rs12012519 HIV/AIDS Progression LEurasiaEALong
doi:10.1371/journal.pgen.1001266.t005
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Blood Pressure
Allele frequencies for functional variants in 5 genes associated
with blood pressure – AGT, GNB3, ADRB2, SCNN1a, and SCNN1c
– have previously been shown to be correlated with latitude;
specifically, alleles conferring higher blood pressure seem to
decrease in frequency with distance from the equator [51,52]. This
pattern may be due to selection favoring lower blood pressures in
cooler climates following the out of Africa migration [51,52].
Although none of the blood pressure SNPs included in our study
are close enough to any of these five genes to be in linkage
disequilibrium with them, we observed that two blood pressure
study groups were significant for measures assessing allele
frequency correlation with latitude – a hypertension study group
[17] containing SNPs whose allele frequencies correlated with
distance from the equator in Africa (LAfricaLatDE) in both the
unsigned and signed analyses, and a diastolic blood pressure study
group [17] that contained SNPs whose allele frequencies
correlated with latitude in Eurasia (LEurasiaLat) in the unsigned
analysis. We reviewed the results of the unsigned analysis and
found that 4 out of 5 total blood pressure study groups had p-
values less than 0.05 for LEurasiaLat and 3 out of 5 had p-values
less than 0.05 for LWorldLat. We then reviewed all II blood
pressure SNPs individually and found that 7 out of 8 of them had
p-values less than 0.1 for LEurasiaLat. However, in Eurasia the
frequency of the allele associated with higher blood pressure is not
always negatively associated with latitude. One of the blood
pressure SNPs whose risk allele for higher blood pressure is
positively correlated with latitude in Eurasia is rs3184504, a non-
synonymous SNP in SH2B3. The rs3184504 T allele, which is
associated with increased blood pressure, was recently shown to
cause increased cytokine production [53] and is believed to have
experienced positive selection in Europe in response to an
infectious disease [22,53]. Of the 8 risk alleles for II blood
pressure SNPs, this is the only allele that is strongly positively
correlated with latitude across all 53 HGDP populations. Most of
the remaining risk alleles are negatively correlated with latitude
when all 53 HGDP populations are considered, much like the risk
alleles in AGT, GNB3, ADRB2, SCNN1a, and SCNN1c [51].
rs3184504 was also the only II blood pressure SNP where there
was strong selection in Eurasia in favor of the risk allele as
measured by iHS. Overall, we observed that allele frequencies at
blood pressure SNPs are often highly correlated with latitude,
especially in Eurasia, although the risk allele for higher blood
pressure is not always negatively associated with latitude. This may
be due to the pleiotropic effects of blood pressure SNPs on other
traits, as could be the case with rs3184504.
Variants Associated with Infectious Disease Resistance
and Autoimmune Disease
Polymorphisms with effects on the immune system are thought
to be under selection in many organisms including primates [54].
In human-specific genome-wide scans for selection, more than 300
immunological genes have been ‘‘hits’’ and when only those genes
involved in recent sweeps are considered, immunity genes are
over-represented relative to genes with other functions [55]. Many
focused studies of individual or groups of immunological genes
have also found patterns of genetic variation consistent with the
effects of selection [56–75]. Included among these studies are
many investigations of loci associated malaria resistance [60–65].
Some of these studies focus on genes like G6PD [61], HBB [64],
and DARC [62,63], which are associated with protection from
malaria but may not be typically thought of as immunological
genes. In much the same way, genes generally associated with
immune function and those associated with autoimmune and
infectious diseases by GWAS are not necessarily the same thing.
384 immunity-related genes have either been hits of genome-wide
selection scans or have been identified as under selection since the
human-chimpanzee split [55]. Of the 258 autoimmune and
infectious disease SNPs that we considered here, only 16 were in
any of these genes and only a further 88 were within 1 MB of any
of them. Despite this, we identified one infectious disease trait and
one autoimmune disease trait whose associated variants consis-
tently produced elevated measure scores. We also observed that
infectious and autoimmune disease SNPs had generally elevated
scores for many different measures (Figure S1). This suggests either
that selection on autoimmune and infectious disease traits may
commonly influence genomic loci not typically associated with
immunity or that there may be selection acting on immunity-
related loci that has not been detected by previously applied
methods.
Although HIV has caused significant mortality in humans for
less than 50 years, alleles at some variants associated with
resistance to HIV infection and delayed disease progression, most
famously the CCR5-D32 deletion, are thought to have experienced
selection in the past due to their protective role against other
infectious diseases [66,67,76]. We found a study group containing
SNPs associated with HIV/AIDS progression [18] that was
significant for iHS in Europe in both unsigned and both signed
analyses. This is not particularly surprising as both SNPs in this
study group are located close to the HLA region on chromosome
6, which is thought to be strongly affected by selection in many
populations including Europeans [57–59]. More notable perhaps
are our results for two X-linked SNPs associated with HIV/AIDS
progression by Fellay et al. [33]. Although separated by more than
40MB on the long arm of the X chromosome, the allele
frequencies of both variants were found to be significantly
correlated with longitude in Eurasia and East Asia (LEurasiaEA-
Long), while rs17324272 was also found to be significant for
LEALong and for iHS in East Asia (Figure 3). Another X-linked
variant, rs5968255, which is located nearly 4MB from
rs17324272, was not included in our original analyses, but was
found to be associated with HIV viral load in another study by the
same authors [77]; we calculated its p-value for LEurasiaEALong
to be 6.136610
25, far below the significance cutoff for our X
chromosome analysis. All three X-linked SNPs had low p-values
for many of the measures assessing correlation of allele frequencies
with longitude in Eurasia and East Asia, for iHS in East Asia, and
for delta measures comparing Eurasian, American, and Oceanic
populations with East Asian populations. The study group
containing the autosomal SNPs identified by Fellay et al. [33]
was found to have low p-values for many of the same measures in
the unsigned group analysis. These measures include iHS in East
Asia, for which the Fellay et al. [33] study group had the lowest p-
value out of all 270 groups, 8.65610
24, even though only one out
of the 19 SNPs in this study group is located in the HLA region
(Figure 3). This evidence suggests that variants associated with
HIV viral load and progression may be collectively under selection
across the Eurasian continent, particularly in East Asian
populations.
As with the variants associated with characteristics of HIV
infection, SNPs associated with autoimmune diseases may have
experienced selection due to their interactions with infectious
pathogens. The hygiene hypothesis postulates that the same alleles
that bolster the immune system in the presence of infection may
lead to autoimmune disease in its absence [78]. This hypothesis is
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variants are sometimes protective against infectious disease [79]
and that the frequencies of some of these risk alleles are positively
correlated with pathogen diversity [78]. We found evidence
among our results to support the idea that some risk alleles for
autoimmune disease have experienced positive selection in the
past. In particular, many of the SNPs associated with psoriasis in
four different GWAS studies produced high iHS scores for all
continents except Oceania and America; the longer haplotypes
centered at these loci were almost always associated with the
psoriasis risk allele (Figure 4). As a result of this, at least one (and
often both) of the two psoriasis study groups [80,81] included in
the signed group analysis of all 1,336 GWAS SNPs had a p-value
#0.05 for iBantu, iME, iEurope, iCA, and iEA. While psoriasis
has been associated with loci in the HLA region, neither of these
two study groups included an HLA SNP. iHS scores for a
psoriasis-associated HLA SNP from a third study [19] indicated
that selection on this locus also tends to favor the psoriasis risk
allele in Africa, Eurasia, and East Asia (Figure 4). In addition, we
observed that one psoriasis study group [19] was significant for Fst
among African Agriculturists in both unsigned group analyses; this
indicates that the force which led to the elevated iHS scores for
psoriasis SNPs in the Bantu may have caused large differences in
allele frequencies at the same SNPs between the Bantu,
Mandenka, and Yoruba.
Of the 16 autoimmune diseases that have been examined by
GWAS, psoriasis produced the highest iHS values for the highest
number of continental regions. At least one psoriasis study group
had a p-value #0.05 for iBantu, iME, iEurope, iCA, and iEA in
the signed group analysis of all 1,336 GWAS SNPs. In each case,
the longer haplotypes around the SNPs in these study groups were
associated with the risk allele. We reviewed the signed group
analysis of all 1,336 GWAS SNPs for other autoimmune disease
study groups and found ten other instances where such a study
group had a p-value #0.05 for an iHS score. In all 10 cases, the
group iHS value indicated that longer haplotypes were associated
with the risk allele for the disease. We also reviewed the iHS scores
produced by individual SNPs associated with autoimmune disease.
For each continent, we found that a considerable proportion of
these SNPs produce high iHS scores (Figure 5A). In the majority of
these cases, the risk allele is associated with a longer haplotype
than the protective allele (Figure 5B). Overall, our findings suggest
there could be a general trend which extends across continents for
selection at autoimmune disease GWAS SNPs in favor of risk
alleles.
Sample Ethnicity
In addition to identifying traits that were consistently associated
with low p-values, we also noticed that GWAS SNPs/study groups
tend to have higher empirical p-values for measures involving
Africa, Oceania, and the Americas. This trend is particularly
notable for iHS score (Figure 2 and Figure S3). For all analyses,
with or without pigmentation SNPs, a smaller percent of GWAS
SNPs and study groups have p-values #0.05 for iBantu than for
any other iHS score. More GWAS SNPs and study groups have p-
values #0.05 for iOceania and iAmerica than for iBantu, but these
percentages are still consistently less than observed for iME,
iEurope, iCA, and iEA. Assuming that direct or indirect
association with a trait does indeed increase the probability that
a SNP will be influenced by selection, we would expect that more
than 5% of GWAS SNPs/study groups would fall into the top 5%
of the empirical distribution for an iHS score. LD patterns vary
between human populations, so that a SNP linked to a causative
variant in Europe may not be linked to that causative variant
elsewhere, especially in Africa where LD patterns vary widely
within the continent as well as differing from those of non-African
populations. The majority of GWAS SNPs were identified as being
trait-associated in European subjects; in African and to a lesser
extent in Oceanic and American populations, GWAS SNPs may
Figure 4. iHS scores for psoriasis SNPs. iHS scores are positive
when selection favors the risk allele for psoriasis. The dark blue bars
represent rs2201841 at position 67,466,790 on chromosome 1. The red
bars represent rs4085613 at position 150,816,642 on chromosome 1.
The green bars represent rs20541 at position 132,023,863 on
chromosome 5. The purple bars represent rs3213094 at position
158,683,347 on chromosome 5. The teal bars represent rs10484554 at
position 31,382,534 on chromosome 6. The orange bars represent
rs2395029 at position 31,539,759 on chromosome 6. The light blue bars
represent rs610604 at position 138,241,110 on chromosome 6. The pink
bars represent rs2066808 at position 55,024,240 on chromosome 12. It
should be noted that both rs10484554 and rs2395029 are in the HLA
region and are less than 1MB apart.
doi:10.1371/journal.pgen.1001266.g004
Figure 3. Delta, LLC, and iHS P-values for HIV/AIDS progression
SNPs in Eurasia and East Asia. The figure displays p-values for
specific Eurasian and East Asian delta, LLC, and iHS measures for HIV/
AIDS Progression SNPs. P-values for these measures are also shown for
the Fellay et al. [33] study group in the unsigned group analysis. The
blue bars represent rs17324272 at position 131,964,822 on chromo-
some X. The red bars represent rs12012519 at position 87,077,005 on
chromosome X. The green bars represent rs5968255 at position
83,141,348 on chromosome X. The purple bars represent the Fellay et
al. [33] study group.
doi:10.1371/journal.pgen.1001266.g003
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probability that they would be affected by selection. If this is the
true explanation for our observations, then SNPs identified by
GWAS using Eurasian subjects and by those using non-Eurasian
subjects may not be the same. Given the limited number of GWAS
studies with non-European subjects, we were only able to test this
hypothesis directly by comparing European and East Asian
GWAS studies. We found that at least for height, T2D, and
SLE, GWAS studies done in Europe and in East Asia tend to
identify the same genomic regions. However, as roughly similar
numbers of GWAS SNPs/study groups have p-values #0.05 for
iEurope and iEA, this is not surprising. Further GWAS studies in
non-European populations are needed to ascertain if trait-SNP
associations are generally universal or if they instead vary
considerably from one human population to the next.
The Influence of Selection and the Genetic Architecture
of GWAS Traits on the Results
Despite our broad-based approach, we found only a few
examples of what may be a polygenic response to a single selective
pressure. We did use stringent significance criteria which might
mean that additional examples can be found among the study
groups that did not quite meet our threshold of significance. It may
also be that there is something about ‘‘GWAS’’ traits and their
underlying genetics that served to undermine our approach.
First, it is likely that the common SNP variants that we have
studied here do not themselves contribute to phenotypic variation.
Rather, it is usually assumed that these genotyped variants are in
high LD with common causative variants [3]. If this were generally
the case, we would expect our approach to still be sound, although
as the LD decreases between the two common variants the
population structure of the causal variant might not be fully
transmitted to the genotyped variant. However, there has been
much speculation lately about the importance of rare variants in
human phenotypic variation [2,3,82]. Goldstein and colleges [2,3]
have demonstrated that causative rare variants tend to be
associated with one allele of nearby common variants, creating
the appearance that these common alleles themselves are
associated with a trait. The authors call these ‘‘synthetic
associations’’. Specifically, they think that common variants may
be linked to small clusters of rare causal variants [2,3]. If this is the
case, it seems unlikely that the population structure of a cluster of
rare variants could be fully characterized by a single linked
common variant. That is, it is quite possible for any or all the rare
variants in such a cluster to have a high Fst score or clinal pattern
which is not reflected in the common variant. iHS might be an
exception to this. Rare copy number variants may also play an
important role in human phenotypic variation [83]; we would
expect them to affect our analysis in much the same way that rare
SNPs would.
Second, even if common variants alone, whether they are the
genotyped variants themselves or in LD with genotyped variants,
are responsible for variation in GWAS traits, our approach may be
undermined by other features of the genetic architecture of these
traits. Specifically, epistasis may be widespread among polymor-
phic sites in the human genome and can be difficult to detect,
particularly as the number of putatively interacting loci considered
increases. Epistasis has been frequently found to exist between loci
in model organisms like flies and mice [84,85]. Additionally, its
effects can be larger than and in the opposite direction as the
individual effects of the interacting loci [84]. It may also be quite
possible that many, even most, GWAS SNPs are associated with
more than one trait. Like epistasis, pleiotropy has been found to be
common for variants influencing complex traits in model
organisms [84,85] and we found multiple instances of it in the
dataset that we studied here. The presence of epistasis and
pleiotropy can mean that the response of a variant to selection is
dependent on the genetic background and the existence and
strength of selection on other traits, complexities we did not
account for in our analysis.
Lastly, the type of selection acting on GWAS traits may not be
well detected by our methods. Some of these traits may simply be
limited in their fitness effects, with little or no selection acting on
them. Alternatively, GWAS traits may be influenced primarily by
balancing or negative selection. If this selection is fairly uniform
across environments, our measures would likely not detect it (see
Text S2). Also, if negative or balancing selection is particularly
widespread in the human genome, any variant experiencing this
Figure 5. iHS scores for autoimmune disease–associated SNPs. A) The proportion of autoimmune disease (AI) GWAS SNPs with iHS scores in
the 95
th percentile or above for each continent. The cutoff value for the 95
th percentile was determined separately for each continental iHS measure.
This cutoff was 2.04 for iBantu, 1.97 for iME, 2.09 for iEurope, 1.98 for iCA, 2.05 for iEA, 1.99 for iOceania, and 1.98 for iAmerica. B) The proportion of AI
GWAS SNPs with iHS scores in the 95
th percentile or above for each continent where the risk allele is associated with a longer haplotype than the
protective allele.
doi:10.1371/journal.pgen.1001266.g005
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cutoff given the large number of other variants that would have
attained similar measure values. Recent work hasproposed negative
selection as one explanation for what appear to be common non-
neutral patterns of variation in the human genome, such as the
elevation of Fst values in genes and the reduction of diversity at sites
linked to coding and regulatory regions [35,86–88].
Overall, our analyses may have been limited by two factors that
are not yet well understood: the type and strength of the selection
acting on GWAS SNPs and the underlying genetic architecture of
GWAS traits. Theory predicts that these two factors are, in fact,
interrelated as the nature of the selection on a trait can shape the
allele frequency spectrum of causative variants [38,39]. Converse-
ly, it has been proposed that an understanding of allele frequencies
of causative variants may be the best way to empirically discern the
nature of the selection acting on a trait [38,39]. Are there any clues
in our results as to the nature of selection on GWAS SNPs or to
the architecture of GWAS traits? More than 5% of all GWAS
SNPs commonly produced p-values of 0.05 or less for measures
involving Eurasian populations. We feel that this indicates a
general pattern of (possibly weak) selection at GWAS SNPs and/or
linked variants in Eurasia. Included among the measures that were
generally elevated for GWAS SNPs were delta and Fst scores. This
suggests a role for positive selection in shaping patterns of variation
surrounding GWAS SNPs, as it is probably the selective force most
likely to cause notable allele frequency differences between
populations. Our observation that iHS scores were generally
elevated for GWAS SNPs is consistent with the effects of positive
selection as well. However, SNPs under negative selection may
also produce elevated iHS scores. Furthermore, a GWAS trait
under negative selection would tend to have rare causative variants
[38,39]. This would lead to the sequestration of some causative
variants in a limited number of populations and would explain
why p-values for GWAS SNPs are higher for measures involving
African, American, and Oceanic population when most GWAS
are conducted using European subjects. Thus, our results suggest
that both negative and positive selection may influence variation at
GWAS SNPs. Their relative contributions, however, remain
unclear. How do the significant traits (pigmentation, blood
pressure, autoimmune disease, and infectious disease resistance)
differ from the other traits we studied? Are they examples of
positive selection driving polygenic adaptation? If so, are they the
only examples among the traits we studied? Or are the genetic
architectures of these traits somehow simpler than other traits,
perhaps because they are less polygenic (as has been proposed
previously for pigmentation [35])? The definitive answers to these
questions ultimately lie in the identification of the causative
variants underlying GWAS traits.
In summary, we have examined 1,336 trait-associated SNPs in
the 53 CEPH-HGDP populations looking for individual SNPs and
groups of SNPs with unusual allele frequency patterns and
elevated iHS scores. We identified 13 different traits with an
associated SNP or study group that produced a significantly
elevated score for at least one delta, Fst, LLC, or iHS measure, a
small percentage of the total number of traits analyzed. We believe
that the limited number of positive results could be due to our
stringent significance criteria or to features of the genetic
architecture of the traits themselves. Specifically, the roles of rare
variants, epistasis, and pleiotropy in human complex traits are,
although areas of active inquiry, still generally not well understood.
Our measures may also not be optimal for detecting all types of
selection acting on GWAS traits. It has been speculated that
variants underlying complex traits will be influenced primarily by
negative or balancing selection, which may not produce extreme
values for our measures, particularly if these forces are relatively
uniform across populations or are acting on many regions in the
genome.
The SNPs and study groups that were significant were almost all
clustered within four trait classes – pigmentation, blood pressure,
infectious disease, and autoimmune disease. Our results suggest
that the traits encompassed by these trait classes are likely
examples of phenotypes that have undergone evolution by
polygenic adaptation. The pattern of elevated measures was
unique for each of these four trait classes, which would seem to
indicate that a different selective force is driving allele frequency
changes at SNPs within each class. However, we cannot rule out
the possibility that some of the SNPs in these trait classes are
associated with multiple traits and thereby experience multiple
selective pressures. It also remains unclear whether the type and
the strength of the selection acting on a phenotype or the
underlying genetic architecture of a trait was the important factor
in distinguishing significant traits from those that were not
significant in our analysis.
We also found that both SNPs and study groups tend to have
lower p-values for Eurasia and East Asian measures. We theorize
that this may be due to global variation in linkage disequilibrium
patterns, causing SNPs associated with a trait in one population to
be unassociated with that trait in another population. If this is the
correct interpretation of our results, it has important implications
for the future of GWAS as it suggests that the SNPs identified by
two GWAS using samples from two different continents may be
quite different. As almost no GWAS studies have been done using
samples from Africa, Oceania, or the Americas, the three
continents where we observed a deficit of low p-values, it is
impossible at present to test this hypothesis directly. We believe
that extending GWAS analyses to include individuals from these
regions is an important next step in this area of research. Such
studies will elucidate whether SNP-trait associations are generally
universal and if not, have the potential to associate new loci with
traits previously studied in other human populations.
Methods
Independently Identified (II) SNPs
We listed all SNPs identified by NHGRI’s online catalog of
genome-wide association studies [5] in the order of their
chromosomal positions (this included GWAS SNPs not included
in the CEPH-HGDP dataset). A SNP was designated as II if there
was another SNP located within 1MB that was associated with the
same trait (or with a similar trait within the same trait class) in at
least one other GWAS. For instance, we counted a Crohn’s disease
SNP as II if there was an ulcerative colitis SNP within 1MB, and a
hypertension SNP as II if there was a systolic blood pressure SNP
within 1MB. SNPs that were associated with the same trait or with
a similar trait by more than one study were also considered II.
Through this process, we hoped to identify GWAS SNPs that were
likely to have genuine trait associations by excluding SNPs in
genomic regions identified by only one study. This method is,
however, biased against SNPs associated with traits that have been
investigated by a limited number of GWAS. For this reason, we
conducted our analyses using both the full set of 1,336 GWAS
SNPs and the subset of 592 II GWAS SNPs.
Calculation of European MAF
The minor allele frequency (MAF) in Europe was calculated for
each SNP in the Li et al. [12] dataset. We then divided these SNPs
into 11 groups based on MAF, including one group which
contained all SNPs with an MAF of 0 in Europe.
GWAS SNPs in the HGDP Populations
PLoS Genetics | www.plosgenetics.org 11 January 2011 | Volume 7 | Issue 1 | e1001266Calculation of ‘‘LD Score’’
For each of our 640,698 autosomal SNPs and 16,297 X-linked
SNPs, we obtained the value of R
2 between it and any hapmap
SNP within 200KB in CEU individuals from the HapMap website
[89]. We then calculated for each SNP the percentage of those R
2
values exceeding 0.8. We used the value of this percentage, which
we will refer to as our ‘‘LD score’’, to divide both our autosomal
and X-linked SNPs into 9 different LD score bins of approximately
the same size. One of these bins (referred to as ‘‘NA’’ in Figure 1)
contains all SNPs that are fixed in Europe.
Standardized Scores and Empirical Distributions for the
Individual and Unsigned Group Analyses
We divided the 640,698 SNPs from the Li et al. [12] dataset into
99 bins (9 groups based on LD score and 11 groups based on
MAF). For each SNP and each measure, we calculated a
standardized score equal to the difference between the SNP’s
value for that measure and the bin average for that measure (as
each GWAS SNP is assigned to a bin based on its MAF and LD
score) divided by the standard deviation of the measure values in
that bin. The SNP was then assigned an empirical p-value for that
measure by comparing its standardized score to the standardized
score of all other 640,698 autosomal SNPs for that measure. This
is the p-value used in the individual SNP analysis. We used this
same procedure to carry out our analysis of the X chromosome
using our 16,297 X-linked SNPs. For the unsigned group analysis,
we created an empirical distribution for each group size n and
each measure by randomly drawing n values from the list of
standardized scores for that measure 1,000,000 times and then
taking the average standardized score for the n values. The p-value
for each study group and each measure was assigned by
comparing the average standardized score for the study group to
the corresponding list of 1,000,000 averages.
Standardized Scores and Empirical Distributions for the
Signed Group Analyses
For our signed group analyses, we determined the risk allele for
as many of the CEPH-HGDP GWAS SNPs as possible. We then
calculated values for these SNPs for the 38 delta, LLC, and iHS
measures with respect to the risk allele as follows. Delta values
were positive if the risk allele frequency was higher in the second
population than in the first. Latitude/Longitude correlation values
were positive if there was a positive correlation between latitude or
longitude and the frequency of the risk allele. iHS values were
positive if selection on the SNP favored the risk allele. Some
GWAS traits are physiological rather than pathological, with
alleles at associated SNPs favoring one side of the physiological
spectrum. For such traits, we picked one end of this physiological
spectrum to represent the ‘‘disease’’ end and denoted alleles
favoring this end as risk alleles. We used this assignment for all
studies of that trait. For instance, there are many GWAS studies
that examine height. We deemed all alleles favoring taller stature
to be risk alleles and used this system for all height GWAS.
To calculate p-values for this part of the analysis, we
recalculated the standardized score for each SNP and each
measure. In the individual and unsigned group analysis, we used
only the absolute values of the delta, Fst, LLC, and iHS measures
in our calculation of standardized scores and in our construction of
the empirical distributions. That is, each SNP had only one
corresponding value and one standardized score for each measure.
In this phase of the analysis, for each SNP and each measure, we
included both the value of the measure and its additive inverse in
our calculations of standardized scores. For each measure and
each study group size n, we created the empirical distributions in
the same way as for the unsigned group analysis, except that we
drew from a list of 1,281,396 standardized scores (since each of the
640,698 SNPs in our dataset ‘‘contributed’’ two standardized
scores instead of one).
Overrepresentation of a Trait Class in the Top 5% Tail of
the Empirical Distribution
For each phase of our analysis of autosomal CEPH-HGDP
GWAS SNPs, we divided all GWAS SNPs or study groups into 18
trait classes (see Table S1). We then determined whether any of
these 18 trait classes were over-represented in the top 5% of the
empirical distribution, given the number of SNPs or study groups
in the trait class. To explain how we did this, we will use a specific
example. In the individual SNP analysis for all 1,336 GWAS
SNPs, the autoimmune disease trait class contained 216 SNPs. For
DPygmy, there are 1,336 total p-values, one corresponding to each
CEPH-HGDP GWAS SNP. We randomly drew 216 p-values
from our list of 1,336 p-values 10,000 times, each time counting
the number of p-values that were #0.05. From this list of 10,000
values, we determined that only 5% of the time did a random
draw of 216 values contain 13 or more values that were #0.05. If
there had been more than 13 autoimmune disease SNPs that had a
p-value #0.05 for DPygmy, we would have said that autoimmune
disease SNPs were over-represented in the 5% tail of the empirical
distribution of DPygmy p-values (there were only 11 in this case).
We repeated this procedure for all trait classes and all delta, Fst,
LLC, and iHS measures for the individual SNP analysis with the
full set of 1,336 GWAS SNPs. We then conducted the same
procedure for the individual SNP analysis of just II SNPs and the
four group analyses, with study groups substituted for individual
SNPs. The full results of these calculations are shown in Figure S1.
In the ‘‘Sample Ethnicity’’ section, we used the same method to
determine if East Asian GWAS SNPs or study groups were
overrepresented in the top 5% of the empirical distribution for any
of our measures.
Literature Review for Sample Ethnicity
We used NHGRI’s GWAS catalog to find the primary sources
for the GWAS results listed on the website [5]. We reviewed these
sources to determine the ethnicity of the samples used in each
GWAS. We included samples that were used for replication
analyses as well as those that were used for initial or discovery
analyses. Individuals from the United States, Canada, or Australia
that were described as ‘‘white’’, ‘‘Caucasian’’, or of European
ancestry were considered European. African Americans from the
United States were considered to be an admixed population. The
one study that we reported as having been done on African
samples used individuals native to the African continent.
Wilcoxon Test Comparing Asian and European GWAS
SNPs and Study Groups
For each delta, Fst, LLC, and iHS measure in the individual
SNP analysis of all GWAS SNPs, we made a list of all the p-values
associated with East Asian GWAS SNPs and a list of all of the
p-values associated with European GWAS SNPs. We used a one-
tailed, unpaired Wilcoxon test to determine if the European
p-values were less than the East Asian p-values or if the East Asian
p-values were less than the European p-values. We then repeated
this procedure for the II individual SNP analysis and all four group
analyses. All of the comparisons we discuss in the results section
had a p-value of 0.05 or less. The results of all tests are shown in
Figure S5.
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We listed all SNPs associated with height (including those not in
the Li et al. [12] dataset) in order of their genomic positions. Any
two SNPs that were less than 1MB apart were grouped together
into one region. For this analysis, we considered only regions
containing more than one SNP (regions defined by one SNP that
was identified in more than one GWAS qualify as containing more
than one SNP). For height, there were 26 such regions. We
repeated this procedure for T2D and SLE.
Supporting Information
Figure S1 Trait Classes "Over-Represented" in the Top 5% of
the Empirical Distribution. The grid is divided into 6 sections, one
for each phase of analysis - individual SNP, unsigned group, and
signed group with both the full set of 1,336 GWAS SNPs and the
subset of 592 independently identified SNPs. Each row corre-
sponds to a particular delta, Fst, LLC, or iHS measure, listed in
the first column. Each column corresponds to a particular trait
group: "O" represents Other, "D" represents Drug Effectiveness
and Side Effects, "C" represents Cancer, "BV" represents
Behavioral/Psychological, "SL" represent Serum Levels, "MT"
represents Metabolic, "ID" represents Infectious Disease, "ND"
represents Neurodegenerative, "AI" represents Autoimmune,
"CV" represents Cardiovascular, "PG" represents Pigmentation,
"BP" represents Blood Pressure, "MS" represents Musculoskeletal,
"HE" represents Hematological, "AP" represents Anthropomor-
phic, "CS" represents Cardiac Structure and Function, "PL"
represents Pulmonary, and "CG" represents Cognition. Each
individual square of the grid corresponding to one measure and
one trait class gives the proportion of SNPs or study groups in that
trait class that have p-values #0.05 for that measure. Squares are
highlighted if members of a trait class are over-represented in the
top 5% of the empirical distribution for a particular measure (see
Methods for how we determined over-representation of a trait
class in the top 5% of the empirical distribution).
Found at: doi:10.1371/journal.pgen.1001266.s001 (0.30 MB
DOC)
Figure S2 Proportion of SNPs and Study Groups with P-Values
#0.05 for the Delta, Fst, and LLC Measures. A) The blue bars
represent the proportion of SNPs in the individual analysis of
1,336 GWAS SNPs that had a p-value of 0.05 or less for each
measure. The red bars represent the proportion of study groups in
the unsigned group analysis with a p-value of 0.05 or less for each
measure. The green bars represent the proportion of study groups
in the signed group analysis with a p-value of 0.05 or less for each
measure. B) The same as in A) except that the blue, red, and green
bars represent the individual SNP, group unsigned, and group
signed analyses for the subset of 592 II SNPs, respectively.
Found at: doi:10.1371/journal.pgen.1001266.s002 (0.10 MB
DOC)
Figure S3 Proportion of SNPs and Study Groups, excluding
those associated with Pigmentation, with P-Values #0.05 for the
Delta, Fst, LLC, and iHS Measures. The same as in Figure 2 and
Figure S3 except that SNPs and study groups associated with
pigmentation have been removed from consideration.
Found at: doi:10.1371/journal.pgen.1001266.s003 (0.09 MB
DOC)
Figure S4 Proportion of Asian GWAS SNPs in the Top 5% of
the Empirical Distribution. Each row represents a particular
measure, listed in the first column. Each column represents one of
the 6 phases of our analysis. A grid square gives the proportion of
East Asian SNPs or study groups in that phase of the analysis with
p-value less than or equal to 0.05 for the corresponding measure.
Squares are highlighted if East Asian GWAS SNPs or study groups
are over-represented in the top 5% of the empirical distribution for
that particular measure (see Methods for how we determined if
East Asian GWAS SNPs or study groups were over-represented in
the top 5% of the empirical distribution).
Found at: doi:10.1371/journal.pgen.1001266.s004 (0.06 MB
DOC)
Figure S5 Comparison of P-Values for European and East
Asian GWAS SNPs. Each row represents a measure, given in the
first column. Each pair of columns represents one of the 6 phases
of our analysis. For the first column in each pair, we compared the
p-values of European and East Asian SNPs or study groups using
an unpaired Wilcoxon test with the hypothesis that European p-
values were less than East Asian p-values. For the second column
in each pair, we instead used the hypothesis that East Asian p-
values were less than European p-values. The values in the grid
represent the p-values of these Wilcoxon tests. We highlighted a
grid square when a Wilcoxon test p-value was less than 0.05.
Found at: doi:10.1371/journal.pgen.1001266.s005 (0.12 MB
DOC)
Figure S6 MAFs in Europe and East Asia of Height, T2D, and
SLE GWAS SNPs identified only by Studies using Samples from
One Continent. The red points represent II GWAS SNPs that
were found in genomic regions containing hits only from East
Asian GWAS studies. The blue points represent II GWAS SNPs
that were found in genomic regions containing hits only from
European GWAS studies. This figure shows that the SNPs
represented in red may not have been hits in European studies
because they tend to have low MAFs in Europe. This is not,
however, true of the SNPs represented in blue and their MAFs in
East Asia.
Found at: doi:10.1371/journal.pgen.1001266.s006 (0.05 MB
DOC)
Figure S7 Histograms of X-Linked SNP MAF and LD Score in
Europe. A) The blue bars represent the proportion of the16,297
X-linked SNPs in the Li et al. [12] dataset that have a European
MAF in each MAF bin (see Methods). The red bars represent the
proportion of the 21 X-linked GWAS SNPs that have a European
MAF in each MAF bin. B) The blue bars represent the proportion
of the 16,297 X-linked SNPs that have an LD score in each LD
score bin (see Methods). The red bars represent the proportion of
the 21 X-linked GWAS SNPs that have an LD score in each LD
score bin. The bin referred to as ‘‘NA’’ contains all X-linked SNPs
that are fixed in Europe.
Found at: doi:10.1371/journal.pgen.1001266.s007 (0.08 MB
DOC)
Figure S8 Kendall Tau Rank Correlation Coefficients for
European MAF and LD Score versus Measure P-Value. Each
row represents a measure, given in the first column. The second
column gives the value of the Kendall tau rank correlation
coefficient between MAF in Europe and measure p-value while
the third column gives the p-value of this coefficient. The fourth
column gives the value of the Kendall tau rank correlation
coefficient between LD score and measure p-value while the fifth
column gives the p-value of this coefficient. Coefficient p-values
less than 0.05 are highlighted.
Found at: doi:10.1371/journal.pgen.1001266.s008 (0.08 MB
DOC)
Figure S9 Plots of DEuropeCA and LEurasiaLat P-Values
versus MAF and LD Score in Europe. A) Each point represents a
GWAS SNPs. The x-axis represents MAF in Europe and the
GWAS SNPs in the HGDP Populations
PLoS Genetics | www.plosgenetics.org 13 January 2011 | Volume 7 | Issue 1 | e1001266y-axis represents p-values for DEuropeCA. B) The same as in A)
except that the x-axis represents LD Score in Europe. C,D) The
same as in A,B) except that the y-axis represents p-values for
LEurasiaLat.
Found at: doi:10.1371/journal.pgen.1001266.s009 (0.15 MB
DOC)
Table S1 List of 18 trait classes.
Found at: doi:10.1371/journal.pgen.1001266.s010 (0.07 MB
DOC)
Text S1 Relationship between European MAF/LD score and
measure P-value.
Found at: doi:10.1371/journal.pgen.1001266.s011 (0.04 MB
DOC)
Text S2 Selection on GWAS SNPs and traits.
Found at: doi:10.1371/journal.pgen.1001266.s012 (0.03 MB
DOC)
Text S3 Population stratification in GWAS samples.
Found at: doi:10.1371/journal.pgen.1001266.s013 (0.03 MB
DOC)
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